Antiplatelet agents for prevention of pre-eclampsia and its consequences: a systematic review and individual patient data meta-analysis

BACKGROUND: There is now good evidence that antiplatelet agents (principally low dose aspirin) prevent pre-eclampsia, a leading cause of morbidity and mortality for pregnant women and their babies. A Cochrane Review identified moderate, but clinically important, reductions in the relative risks of p...

Descripción completa

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC555958/
https://www.ncbi.nlm.nih.gov/pubmed/15833147
http://dx.doi.org/10.1186/1471-2393-5-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC555958/
https://www.ncbi.nlm.nih.gov/pubmed/15833147
http://dx.doi.org/10.1186/1471-2393-5-7

Ejemplares similares